GPP

Great Point Partners Portfolio holdings

AUM $308M
1-Year Est. Return 183.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+183.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$454M
AUM Growth
+$70.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$20.3M
2
+$17.6M
3
+$17.2M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$16.1M
5
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$13.9M

Top Sells

1
+$18.2M
2
+$11.2M
3
+$7.57M
4
PLXP
PLx Pharma Inc. Common Stock
PLXP
+$2.59M
5
PDLI
PDL BioPharma, Inc.
PDLI
+$2.16M

Sector Composition

1 Healthcare 87.1%
2 Technology 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$44M 9.69%
2,601,351
2
$33.3M 7.34%
3,000,000
+230,575
3
$32.1M 7.07%
2,010,000
-696,134
4
$30.3M 6.68%
4,973,509
-1,448,723
5
$29.7M 6.54%
2,440,959
6
$29M 6.4%
750,000
+355,920
7
$27.7M 6.12%
828,253
+38,253
8
$21.2M 4.67%
4,000,000
+524,773
9
$20.4M 4.5%
635,500
+325,102
10
$19.7M 4.35%
413,179
+32,084
11
$19.7M 4.34%
385,683
+120,790
12
$18.9M 4.17%
+65,520
13
$17.6M 3.89%
+4,801
14
$15.9M 3.51%
437,865
+37,865
15
$14.4M 3.19%
+1,000,000
16
$13M 2.87%
37,000
+23,855
17
$11M 2.42%
3,055,000
+375,000
18
$9.15M 2.02%
375,000
+351,481
19
$7.79M 1.72%
+270,000
20
$6.93M 1.53%
4,127,232
21
$5.57M 1.23%
43,939
+13,551
22
$4.35M 0.96%
+350,000
23
$4.13M 0.91%
870,261
+642,604
24
$4.12M 0.91%
1,963,777
25
$3.46M 0.76%
114,080
-565,323
1
2